» Articles » PMID: 39506064

Smad Transcription Factors As Mediators of 7 Transmembrane G Protein-coupled Receptor Signalling

Overview
Specialty Pharmacology
Date 2024 Nov 6
PMID 39506064
Authors
Affiliations
Soon will be listed here.
Abstract

The Smad transcription factors are well known for their role at the core of transforming growth factor-β (TGF-β) signalling. However, recent evidence shows that the Smad transcription factors play a vital role downstream of other classes of receptors including G protein-coupled receptors (GPCR). The versatility of Smad transcription factors originated from the two regions that can be differently activated by the TGF-β receptor superfamily or through the recruitment of intracellular kinases stimulated by other receptors classes such as GPCRs. The classic GPCR signalling cascade is further expanded to conditional adoption of the Smad transcription factor under the stimulation of Akt, demonstrating the unique involvement of the Smad transcription factor in GPCR signalling pathways in disease environments. In this review, we provide a summary of the signalling pathways of the Smad transcription factors as an important downstream mediator of GPCRs, presenting exciting opportunities for discovering new therapeutic targets for diseases.

Citing Articles

BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy.

Jiang F, Tang J, Wei X, Pan H, Fan X, Zhang P Chin Med. 2025; 20(1):12.

PMID: 39825396 PMC: 11740616. DOI: 10.1186/s13020-025-01062-9.

References
1.
Rosenbaum D, Rasmussen S, Kobilka B . The structure and function of G-protein-coupled receptors. Nature. 2009; 459(7245):356-63. PMC: 3967846. DOI: 10.1038/nature08144. View

2.
Sriram K, Insel P . G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?. Mol Pharmacol. 2018; 93(4):251-258. PMC: 5820538. DOI: 10.1124/mol.117.111062. View

3.
Derynck R, Zhang Y, Feng X . Smads: transcriptional activators of TGF-beta responses. Cell. 1998; 95(6):737-40. DOI: 10.1016/s0092-8674(00)81696-7. View

4.
Ankeny R, Thourani V, Weiss D, Vega J, Taylor W, Nerem R . Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6. PLoS One. 2011; 6(6):e20969. PMC: 3115968. DOI: 10.1371/journal.pone.0020969. View

5.
Tsuchida K, Nakatani M, Hitachi K, Uezumi A, Sunada Y, Ageta H . Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal. 2009; 7:15. PMC: 2713245. DOI: 10.1186/1478-811X-7-15. View